View |
|
DR-XY43936
|
Gliclazide +Metformin Hydrochloride
|
Melanov- M
|
80 mg/500 mg
|
Tablet
|
Oral Hypoglycemic
|
Micro Labs Limited
|
India
|
Initial (from Monitored Release status)
|
30 May 2022
|
02 December 2024
|
View |
|
DR-XY43937
|
Terbinafine (as hydrochloride)
|
Erbinox
|
10mg/g (1%w/w)
|
Cream
|
-
|
Apex Laboratories Private Limited
|
India
|
-
|
19 December 2019
|
02 December 2024
|
View |
|
DR-XY43938
|
Tranexamic acid + Mefenamic acid
|
Traxan Plus
|
500mg/250mg
|
Film Coated Tablet
|
-
|
Concept Pharmaceuticals Ltd.
|
India
|
-
|
23 September 2019
|
02 December 2024
|
View |
|
DR-XY43939
|
Tramadol Hydrochloride
|
None
|
50 mg
|
Film-Coated Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
16 September 2019
|
04 December 2024
|
View |
|
DR-XY43944
|
Finasteride
|
Vexfin 5
|
5mg
|
Film-Coated Tablet
|
Benign Prostatic Hypertrophy
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
Renewal
|
10 March 2024
|
03 December 2029
|
View |
|
DR-XY43946
|
Loratadine
|
Claritin Reditabs
|
10 mg
|
Oral Disintegrating Tablet
|
-
|
Catalent UK Swindon Zydis Limited
|
United Kingdom
|
-
|
23 January 2020
|
03 December 2024
|
View |
|
DR-XY43955
|
Azithromycin (as Dihydrate)
|
Azilife 500
|
500mg
|
Film-Coated Tablet
|
Macrolide
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Automatic Renewal
|
12 January 2022
|
10 December 2026
|
View |
|
DR-XY43959
|
Amoxicillin (as trihydrate) + Clavulanic Acid (as Potassium clavulanate)
|
Sullivan
|
400mg/ 57mg per 5mL
|
Powder for Suspension
|
Antibacterial (Penicillin) + Beta-lactamase Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
02 November 2021
|
13 November 2026
|
View |
|
DR-XY43960
|
Domperidone (As Maleate)
|
Motilia
|
10mg
|
Tablet
|
-
|
2 World Laboratories
|
India
|
-
|
06 April 2020
|
11 March 2025
|
View |
|
DR-XY43961
|
Fluticasone propionate + Formoterol fumarate dihydrate
|
Flutiform
|
50 mcg/ 5 mcg per actuation
|
Metered Dose Inhaler (Suspension)
|
Adrenergic-Corticosteroid Combination
|
Recipharm HC Limited
|
United Kingdom
|
Initial (from Monitored Release)
|
01 December 2021
|
22 December 2024
|
View |
|
DR-XY43963
|
Diosmin + Hesperidin
|
Vesogen
|
450/50 mg
|
Film-Coated Tablet
|
Vasoprotective
|
The ACME Laboratories
|
Bangladesh
|
Renewal
|
04 September 2024
|
10 December 2029
|
View |
|
DR-XY43964
|
Fluticasone propionate + Formoterol fumarate dihydrate
|
Flutiform
|
125 mcg/ 5 mcg per actuation
|
Metered Dose Inhaler (Suspension)
|
-
|
Recipharm HC Limited
|
United Kingdom
|
-
|
01 December 2021
|
22 December 2024
|
View |
|
DR-XY43967
|
Citicoline sodium
|
Neurovell
|
125mg/mL
|
Solution For Injection (IM/IV)
|
Nootropic
|
PT. Novell Pharmaceutical laboratories
|
Indonesia
|
Renewal
|
25 August 2024
|
10 December 2029
|
View |
|
DR-XY43980
|
Risedronic Acid (As Risedronate Sodium)
|
Actonate
|
32.5 mg (equivalent to 35 mg Risedronate Sodium)
|
Film-Coated Tablet
|
-
|
Aprogen Pharmaceuticals, Inc.
|
Korea
|
-
|
10 October 2019
|
15 December 2024
|
View |
|
DR-XY43984
|
Co-Amoxiclav
|
Moxiklav
|
1.2g
|
Powder For Injection (Iv)
|
-
|
Sichuan Pharmaceutical Inc.
|
China
|
-
|
03 January 2020
|
17 December 2024
|
View |
|
DR-XY43992
|
Risperidone
|
Noprenia
|
2mg
|
Film Coated Tablet
|
Antipsychotic
|
PT. Novell Pharmaceutical laboratories
|
Indonesia
|
Renewal
|
25 July 2024
|
16 December 2029
|
View |
|
DR-XY43996
|
Zonisamide
|
Zonegran
|
100mg
|
Film-Coated Tablet
|
Antiepileptics (Other Antiepileptics)
|
Bora Pharmaceuticals Co., Ltd.
|
Taiwan
|
Renewal
|
24 January 2024
|
16 December 2029
|
View |
|
DR-XY43997
|
Metformin Hydrochloride + Glipizide
|
Dibizide - M
|
500 mg/5 mg
|
Tablet
|
Oral hypoglycemic ( Biguanide and Sulfonylurea Combination )
|
Micro Labs Limited
|
India
|
Renewal
|
04 August 2024
|
16 December 2029
|
View |
|
DR-XY43999
|
Ranolazine
|
Cartinex-OD
|
1g
|
Extended Release Tablet
|
Anti-Angina
|
Micro Labs Ltd.
|
India
|
Initial
|
16 February 2022
|
16 December 2024
|
View |
|
DR-XY44001
|
Ranitidine Hydrochloride/Tripotassium Bismuth Dicitrate/Sucralfate
|
Albis
|
84mg/100mg/300mg
|
Film Coated Tablet
|
-
|
Daewoong Pharmaceutical Co., Inc.
|
Korea
|
-
|
11 September 2019
|
17 December 2024
|